FDA 483 - C.J. Labs, Inc. - September 25, 2019

An FDA inspection of G&G Labs, Inc. in Miami, FL, from September 23-25, 2019, revealed a significant quality control deficiency. The firm failed to calibrate instruments and controls used in manufacturing and testing dietary supplements, including critical HPLC equipment. This indicates a systemic issue with ensuring the accuracy and precision of their testing processes.